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APPENDIX
.
Pre and postAVR characteristics in study population compared to patients who had AVR without a preAVR CPX during the study period.
Study Group n=37
Reference 
Representativeness of the study patients
Pre-and post-AVR characteristics in the study population compared to patients who had AVR without a pre-AVR CPX during the study period (Reference group) are shown in Table A3 (appendix). There were no significant differences in important pre-AVR characteristics between the study group and the reference group, besides that 27% were deemed NYHA I in the study group vs.
none in the reference group. Post AVR, the achieved predicted pO 2 pulse was slightly higher in the reference group, which may partly be explained by lower peak heart rates or by chance (multiple comparisons).
Most patients with aortic stenosis who are referred for AVR in our region (800.000 inhabitants) are evaluated at our institution. From the National Heart Registry, the number of AVR patients without revascularization in our region can be calculated to 110 per year. Considering the exclusion criteria as well as that some AVR patients are caused by aortic insufficiency, endocarditis, or a more acute course and that some patients are evaluated outside our institution, the number of potential eligible patients for the study may be estimated to not be higher than 140 to 160 in the two-year study period. Accordingly, it may be estimated that our study patients (n=42) and study + reference (n=42+36) patients present 25 to 30% and 50 to 55% of all potentially eligible patients, respectively. Our patients (study group + reference group) constituted ~15% of the patients in the Notion Study [15] . We have no reasons to believe that our patients were treated differently from contemporary usual care or that they had different outcomes.
